DNA demethylating therapy in MDS:: The experience with 5-AZA-2′-deoxycytidine (decitabine).

被引：0
|
作者：
Wijermans, P
Luebbert, M
Verhoef, G
Bosly, A
Ravoet, C
Andre, M
Ferrant, A
Haak, H
机构：
[1] Leyenburg Hosp, Dept Haematol, The Hague, Netherlands
[2] Univ Freiburg, Freiburg, Germany
[3] Univ Grootgasthuisberg, Louvain, Belgium
[4] Mt Godinne UCL, Yvoir, Belgium
[5] Hosp Jolimont, Haine St Paul, Belgium
[6] Hosp Notre Dame, Charleroi, Belgium
[7] Clin Univ St Luc, B-1200 Brussels, Belgium
来源：
BLOOD | 1999年 / 94卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1368
引用
收藏
页码：306A / 306A
页数：1
相关论文
共 50 条
  • [41] Pharmacokinetic and pharmacodynamic analysis of 5-aza-2’-deoxycytidine (decitabine) in the design of its dose-schedule for cancer therapy
    Metin Karahoca
    Richard L Momparler
    Clinical Epigenetics, 2013, 5
  • [42] Immunomodulatory activity of SGI-110, a 5-aza-2′-deoxycytidine-containing demethylating dinucleotide
    Coral, S.
    Sigalotti, L.
    Parisi, G.
    Colizzi, F.
    Fratta, E.
    Nicolay, H. J. M.
    Taverna, P.
    Maio, M.
    EJC SUPPLEMENTS, 2010, 8 (07): : 173 - 174
  • [43] Immunomodulatory activity of SGI-110, a 5-aza-2′-deoxycytidine-containing demethylating dinucleotide
    Coral, Sandra
    Parisi, Giulia
    Nicolay, Hugues J. M. G.
    Colizzi, Francesca
    Danielli, Riccardo
    Fratta, Elisabetta
    Covre, Alessia
    Taverna, Pietro
    Sigalotti, Luca
    Maio, Michele
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2013, 62 (03) : 605 - 614
  • [44] 5-AZA-2'-DEOXYCYTIDINE THERAPY IN PATIENTS WITH ACUTE-LEUKEMIA INHIBITS DNA METHYLATION
    MOMPARLER, RL
    BOUCHARD, J
    ONETTO, N
    RIVARD, GE
    LEUKEMIA RESEARCH, 1984, 8 (02) : 181 - 185
  • [45] DNA demethylating therapy in MDS: The effect of Decitabine on the platelet count.
    Wijermans, P
    Luebbert, M
    Verhoef, G
    Haak, H
    BLOOD, 1999, 94 (10) : 306A - 306A
  • [46] AN ANALYTICAL STUDY OF 5-AZA-2'-DEOXYCYTIDINE
    TOMANKOVA, H
    ZYKA, J
    PILECKOVA, Z
    MICROCHEMICAL JOURNAL, 1984, 29 (03) : 333 - 340
  • [47] Analysis of genes upregulated by the demethylating agent 5-aza-2′-deoxycytidine in gastric cancer cell lines
    Mikata, Rintaro
    Yokosuka, Osamu
    Fukai, Kenichi
    Imazeki, Fumio
    Arai, Makoto
    Tada, Motohisa
    Kurihara, Tomoko
    Zhang, Kaiyu
    Kanda, Tatsuo
    Saisho, Hiromitsu
    INTERNATIONAL JOURNAL OF CANCER, 2006, 119 (07) : 1616 - 1622
  • [48] 5-aza-2′-deoxycytidine in myelodysplasia.
    Kell, WJ
    Burnett, AK
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 101 : 64 - 64
  • [49] Epigenetic therapy of acute myeloid leukemia using 5-aza-2′-deoxycytidine (decitabine) in combination with inhibitors of histone methylation and deacetylation
    Momparler, Richard L.
    Cote, Sylvie
    Momparler, Louise F.
    Idaghdour, Youssef
    CLINICAL EPIGENETICS, 2014, 6
  • [50] DNA Cytosine-Demethylating Agent 5-Aza-2′-Deoxycytidine Targets Leukemia Cells through Reducing DNA N6-Methyladenine
    Liu, Xiaochang
    Pang, Jiuxia
    Seiler, Christopher
    Kempen, Ryan
    Liu, Hao
    Al-Kali, Aref
    Tretyakova, Y. Natalia
    Litzow, Mark
    Liu, Shujun
    BLOOD, 2019, 134
12345